No Data
No Data
Insider Sale: CHIEF MEDICAL OFFICER of $CMRX Sells 3,065 Shares
Chimerix's Strategic Progress and Upcoming Catalysts: A Promising Outlook for 2025
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
Express News | Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Here's Why Chimerix, Inc. (CMRX) Is Skyrocketing